Zobrazeno 1 - 10 of 36 330 pro vyhledávání: '"Killer Cell"'
1
Akademický článek
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances.
Autor: Greppi M; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy., De Franco F; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy., Obino V; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy., Rebaudi F; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy., Goda R; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy., Frumento D; Department of Education Sciences, University of Rome Tre, Rome, Italy., Vita G; Department of Internal Medicine (DIMI), University of Genoa, Genoa, Italy., Baronti C; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy., Melaiu O; Department of Clinical Sciences and Translational Medicine, University of Rome 'Tor Vergata', Rome, Italy., Bozzo M; Department of Earth, Environmental and Life Sciences (DISTAV), University of Genoa, Genoa, Italy., Candiani S; Department of Earth, Environmental and Life Sciences (DISTAV), University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Vellone VG; Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa, Genoa, Italy; Pathology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy., Papaccio F; Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi, Italy. Electronic address: fpapaccio@unisa.it., Pesce S; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy. Electronic address: silvia.pesce@unige.it., Marcenaro E; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy. Electronic address: emanuela.marcenaro@unige.it.
Publikováno v: Immunology letters [Immunol Lett] 2024 Dec; Vol. 270, pp. 106932. Date of Electronic Publication: 2024 Sep 18.
Zobrazit plný text záznamu
2
Akademický článek
Effect of NK cell receptor genetic variation on allogeneic stem cell transplantation outcome and in vitro NK cell cytotoxicity.
Autor: Nihtilä J; Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland., Penna L; Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland.; Advanced Cell Therapy Centre, Finnish Red Cross Blood Service, Vantaa, Finland., Salmenniemi U; Comprehensive Cancer Center, Stem Cell transplantation Unit, Helsinki University Hospital, Helsinki, Finland.; University of Helsinki, Helsinki, Finland., Itälä-Remes M; Turku University Hospital, Turku, Finland., Crossland RE; Translational and Clinical Research Institute, Faculty of Medical Science, Newcastle University, Newcastle upon Tyne, UK., Gallardo D; Department of Hematology, ICO Girona, Girona, Spain., Bogunia-Kubik K; Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland., Lacina P; Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland., Bieniaszewska M; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland., Giebel S; Department of Bone Marrow Transplantation and Hematology-Oncology, Gliwice Branch, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland., Karjalainen K; Blood Service Biobank, Finnish Red Cross Blood Service, Vantaa, Finland., Jahan F; Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland., Kerkelä E; Advanced Cell Therapy Centre, Finnish Red Cross Blood Service, Vantaa, Finland., Hyvärinen K; Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland., Koskela S; Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland.; Blood Service Biobank, Finnish Red Cross Blood Service, Vantaa, Finland., Ritari J; Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland., Partanen J; Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland. jukka.partanen@veripalvelu.fi.; Blood Service Biobank, Finnish Red Cross Blood Service, Vantaa, Finland. jukka.partanen@veripalvelu.fi.
Publikováno v: Scientific reports [Sci Rep] 2024 Nov 06; Vol. 14 (1), pp. 26988. Date of Electronic Publication: 2024 Nov 06.
Zobrazit plný text záznamu
3
Akademický článek
Germline natural killer cell receptors modulating the T cell response.
Autor: Mora-Bitria L; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom., Asquith B; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
Publikováno v: Frontiers in immunology [Front Immunol] 2024 Nov 04; Vol. 15, pp. 1477991. Date of Electronic Publication: 2024 Nov 04 (Print Publication: 2024).
Zobrazit plný text záznamu
4
Akademický článek
NK-cell receptor modulation in viral infections.
Autor: Lenart M; Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Wielicka, Krakow, Poland., Rutkowska-Zapała M; Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Wielicka, Krakow, Poland., Siedlar M; Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Wielicka, Krakow, Poland.
Publikováno v: Clinical and experimental immunology [Clin Exp Immunol] 2024 Jul 12; Vol. 217 (2), pp. 151-158.
Zobrazit plný text záznamu
5
Akademický článek
ITAM-based receptors in natural killer cells.
Autor: Aguilar OA; Department of Microbiology and Immunology, University of California - San Francisco, San Francisco, California, USA.; Parker Institute for Cancer Immunotherapy, University of California - San Francisco, San Francisco, California, USA., Fong LK; Department of Pharmaceutical Chemistry, University of California - San Francisco, San Francisco, California, USA., Lanier LL; Department of Microbiology and Immunology, University of California - San Francisco, San Francisco, California, USA.; Parker Institute for Cancer Immunotherapy, University of California - San Francisco, San Francisco, California, USA.
Publikováno v: Immunological reviews [Immunol Rev] 2024 May; Vol. 323 (1), pp. 40-53. Date of Electronic Publication: 2024 Feb 27.
Zobrazit plný text záznamu
6
Akademický článek
Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities.
Autor: Bisht, Kamlesh1 (AUTHOR) kamlesh.bisht@sanofi.com, Merino, Aimee2 (AUTHOR), Igarashi, Rob1 (AUTHOR), Gauthier, Laurent3 (AUTHOR), Chiron, Marielle4 (AUTHOR), Desjonqueres, Alexandre1 (AUTHOR), Smith, Eric5 (AUTHOR), Briercheck, Edward5 (AUTHOR), Romee, Rizwan5 (AUTHOR), Alici, Evren6 (AUTHOR), Vivier, Eric3,7,8 (AUTHOR), O'Dwyer, Michael9 (AUTHOR), van de Velde, Helgi1 (AUTHOR)
Publikováno v: Experimental Hematology & Oncology. 11/13/2024, Vol. 13 Issue 1, p1-18. 18p.
Zobrazit plný text záznamu
7
Akademický článek
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies.
Autor: Zu, Yingling1 (AUTHOR), Ren, Quan2 (AUTHOR), Zhang, Jishuai3 (AUTHOR), Su, Hongchang3 (AUTHOR), Lu, Qiumei3 (AUTHOR), Song, Yongping4 (AUTHOR) songyp@zzu.edu.cn, Zhou, Jian1 (AUTHOR) zhoujiandoctor@163.com
Publikováno v: Experimental Hematology & Oncology. 10/26/2024, Vol. 13 Issue 1, p1-16. 16p.
Zobrazit plný text záznamu
8
Akademický článek
A novel NKp80-based strategy for universal identification of normal, reactive and tumor/clonal natural killer-cells in blood.
Autor: Morán-Plata FJ; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca), and Department of Medicine, University of Salamanca, Salamanca, Spain.; Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain., Muñoz-García N; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca), and Department of Medicine, University of Salamanca, Salamanca, Spain.; Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain., González-González M; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca), and Department of Medicine, University of Salamanca, Salamanca, Spain.; Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain., Pozo J; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca), and Department of Medicine, University of Salamanca, Salamanca, Spain.; Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain., Carretero-Domínguez S; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca), and Department of Medicine, University of Salamanca, Salamanca, Spain.; Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Mateos S; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca), and Department of Medicine, University of Salamanca, Salamanca, Spain.; Cell-purification Service, NUCLEUS, University of Salamanca, Salamanca, Spain., Barrena S; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca), and Department of Medicine, University of Salamanca, Salamanca, Spain.; Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain., Belhassen-García M; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain.; Department of Infectious Diseases, University Hospital of Salamanca, Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Salamanca, Spain., Lau C; Laboratory of Cytometry, Unit for Hematology Diagnosis, Department of Hematology, Hospital de Santo António (HSA), Centro Hospitalar Universitário do Porto (CHUP), Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto (UMIB/ICBAS/UP), Porto, Portugal., Teixeira MDA; Laboratory of Cytometry, Unit for Hematology Diagnosis, Department of Hematology, Hospital de Santo António (HSA), Centro Hospitalar Universitário do Porto (CHUP), Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto (UMIB/ICBAS/UP), Porto, Portugal., Santos AH; Laboratory of Cytometry, Unit for Hematology Diagnosis, Department of Hematology, Hospital de Santo António (HSA), Centro Hospitalar Universitário do Porto (CHUP), Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto (UMIB/ICBAS/UP), Porto, Portugal., Yeguas A; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Balanzategui A; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., García-Sancho AM; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca), and Department of Medicine, University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Orfao A; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca), and Department of Medicine, University of Salamanca, Salamanca, Spain.; Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Almeida J; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca), and Department of Medicine, University of Salamanca, Salamanca, Spain.; Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v: Frontiers in immunology [Front Immunol] 2024 Jul 08; Vol. 15, pp. 1423689. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).
Zobrazit plný text záznamu
9
Akademický článek
THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling.
Autor: Deborah EA; Department of Immunology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.; Doctoral Program in Medical Science, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan., Nabekura T; Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba, Tsukuba, Ibaraki, Japan.; R&D Center for Innovative Drug Discovery, University of Tsukuba, Tsukuba, Ibaraki, Japan., Shibuya K; Department of Immunology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.; R&D Center for Innovative Drug Discovery, University of Tsukuba, Tsukuba, Ibaraki, Japan., Shibuya A; Department of Immunology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.; Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba, Tsukuba, Ibaraki, Japan.; R&D Center for Innovative Drug Discovery, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2024 Jun 01; Vol. 212 (11), pp. 1819-1828.
Zobrazit plný text záznamu
10
Akademický článek
Structure of the murine CD94-NKG2A receptor in complex with Qa-1 b presenting an MHC-I leader peptide.
Autor: MacLachlan BJ; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia., Sullivan LC; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Australia., Brooks AG; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Australia., Rossjohn J; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.; Institute of Infection and Immunity, School of Medicine, Cardiff University, UK., Vivian JP; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Publikováno v: The FEBS journal [FEBS J] 2024 Apr; Vol. 291 (7), pp. 1530-1544. Date of Electronic Publication: 2024 Jan 10.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje